Publications by authors named "Matthew Crotty"

Claim this Profile
A
A Retrospective Study Evaluating the Safety and Clinical Impact of High Dose (6.75 grams) Piperacillin-Tazobactam Dosing in Critically Ill Obese Patients for Pneumonia.
Christina X Tran, Matthew P Crotty, Ronda L Akins

J Pharm Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility Assessment of a Pharmacy to Dose Daptomycin Protocol: A Retrospective Cohort Study.
Kevin Burnham, Stefanie Henley, Matthew P Crotty, Ronda L Akins

Ann Pharmacother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of emergency medicine pharmacist impact on blood culture review and management following discharge.
Kevin Burnham, Ronda L Akins, Christina Tran, Matthew P Crotty, Feng Lin

Am J Emerg Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do not treat ghosts: anti-methicillin-resistant (MRSA) therapy in osteomyelitis without identified MRSA.
Jincy Varughese, Annie Halfman, Matthew Crotty, Julie Alexander, Leigh Hunter

Antimicrob Steward Healthc Epidemiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short Versus Long Antibiotic Duration in Bacteremia.
Matthew Crotty, Hadley Devall, Natalie Cook, Francis Fischer, Julie Alexander

Open Forum Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying Gram-Negative Resistance to Empiric Treatment After Repeat ExpoSure To AntimicRobial Therapy (RESTART).
Arya Wibisono, Gaielle Harb, Matthew Crotty, Kristen Rahmanzadeh, Julie Alexander

Open Forum Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Evaluation of Guideline Concordance in the Management of Intra-Abdominal Infections.
M Paul Nguyen, Matthew P Crotty, Betina Daniel, Ed Dominguez

Surg Infect (Larchmt)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning Experiences Within Infectious Diseases Pharmacy Residency Programs in the United States: A Cross-Sectional Survey.
Jonathan C Cho, Matthew P Crotty, Wesley D Kufel, Elias B Chahine, Amelia K Sofjan

Open Forum Infect Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ridinilazole: a novel antimicrobial for infection.
Jonathan C Cho, Matthew P Crotty, Joe Pardo

Ann Gastroenterol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-institution experience with a brucellosis outbreak in the United States.
Riya Joseph, Matthew P Crotty, Jonathan Cho, Marie H Wilson, Jennifer Tran

Am J Infect Control· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced terminal room disinfection and the need for multimodal collaboration.
Matthew P Crotty, Marie H Wilson

Lancet Infect Dis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone.
Jonathan C Cho, Matthew P Crotty, Bryan P White, Marylee V Worley

Pharmacotherapy· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria.
Mark D Gonzalez, Allison R McMullen, Meghan A Wallace, Matthew P Crotty, David J Ritchie

Ann Lab Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Terminal room disinfection: how much BETR can it get?
Matthew P Crotty, Patricia J Jackson

Lancet· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.
Matthew P Crotty, Tamara Krekel, C A Burnham, David J Ritchie

J Clin Microbiol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study.
Matthew P Crotty, Shelby Meyers, Nicholas Hampton, Stephanie Bledsoe, David J Ritchie

Medicine (Baltimore)· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship.
Matthew P Crotty, Shelby Meyers, Nicholas Hampton, Stephanie Bledsoe, David J Ritchie

Crit Care· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks associated with foods having advisory milk labeling.
Matthew P Crotty, Steve L Taylor

J Allergy Clin Immunol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis